NCT04982653

Brief Summary

This clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wall of the abdomen (an abdominal hernia) at the incision site better than the other.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jan 2022

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 18, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 29, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

January 4, 2022

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

November 10, 2025

Status Verified

November 1, 2025

Enrollment Period

4.3 years

First QC Date

June 18, 2021

Last Update Submit

November 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Radiographic incidence rate of incisional hernia

    Definition of incisional hernia will be based on the European Hernia Society: Any abdominal wall gap with or without a bulge in the area of a postoperative scar perceptible or palpable by clinical examination or imaging. Assessment of the primary outcome will occur at 3, 6, and 12 months with a computed tomography scan/magnetic resonance imaging. Scans will be read and assessed for incisional hernia by 3 independent assessors blinded to the allocation. A correlation coefficient will be determined for their assessments. The cumulative incidence rate of incisional hernia at 12 months will be estimated, along with the 95% confidence interval.

    Up to 12 months after surgery

Secondary Outcomes (10)

  • Surgical site infection

    Up to 90 days after surgery

  • Surgical site occurrence

    Up to 90 days after surgery

  • Surgical site occurrence requiring procedural intervention

    Up to 90 days after surgery

  • Postoperative complications

    Up to 90 days after surgery

  • Need for reoperation

    Up to 90 days after surgery

  • +5 more secondary outcomes

Study Arms (2)

Arm I (hepatectomy using small bites fascial closure)

EXPERIMENTAL

Patients undergo hepatectomy as planned using small bites fascial method for abdominal wall closure.

Other: Quality-of-Life AssessmentProcedure: Surgical Procedure

Arm II (hepatectomy using conventional fascial method)

ACTIVE COMPARATOR

Patients undergo hepatectomy as planned using conventional fascial method for abdominal wall closure.

Other: Quality-of-Life AssessmentProcedure: Surgical Procedure

Interventions

Ancillary studies

Also known as: Quality of Life Assessment
Arm I (hepatectomy using small bites fascial closure)Arm II (hepatectomy using conventional fascial method)

Undergo hepatectomy using small bites fascial method for abdominal wall closure

Also known as: Operation, Surgery, Surgical, Surgical Intervention, Surgical Interventions, Surgical Procedures, Type of Surgery
Arm I (hepatectomy using small bites fascial closure)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective surgery
  • Age \>= 18
  • Planned midline laparotomy incision or inverted-L incision

You may not qualify if:

  • Pre-existing abdominal hernia
  • History of mesh placement at prior laparotomy
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Carcinoma, Hepatocellular

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver Diseases

Study Officials

  • Timothy E Newhook, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Timothy E Newhook, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2021

First Posted

July 29, 2021

Study Start

January 4, 2022

Primary Completion

April 30, 2026

Study Completion

April 30, 2026

Last Updated

November 10, 2025

Record last verified: 2025-11

Locations